Triazavirin – as a potential coronovirus M protease inhibitor 2019-nCoV

Abstract

In 2019, a novel Coronavirus 2019-nCoV was found to cause Severe Acute Respiratory symptoms and rapid pandemic in China, France, United States of America, Germany, Italy, Japan, Russia. In order to find candidate drugs for 2019-nCoV. We have carried out a computational study to screen for effective available drug Triazavirin which may work as inhibitor for the Mpro of 2019-nCoV.